To explore the relationship between the MNX1 protein level and clinical prognosis of patients with HER2-positive breast cancer, we used tissue microarray data of 183 patients from our center to perform immunohistochemical staining and scored the patients by the staining intensity of MNX1. Here, ERBB2 is linked to breast cancer.